Here are relevant reports on : precision-fermentation-ingredients-market
-
Novel Food Ingredients Market 2032: Size, Share & Growth Report
Novel food ingredients market size is estimated at USD 5,200.0 million in 2025 and is projected to reach USD 9,510.0 million by 2032, expanding at a 9.0% CAGR.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Botanical Ingredients Market by Type, End-Use Industry, Application and Region – Global Forecast to 2030
Botanical Ingredients Market
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Longevity Ingredients Market - Global Forecast to 2030
Global Longevity Ingredients Market Valued at approximately USD XX billion in 2024, this market is projected to grow at a Compound Annual Growth Rate (CAGR) of X.X% through 2030, reaching USD XX billion.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Seed Ingredients Market - Global Forecast to 2029
The global seed ingredients market is projected to expand from USD XX million in 2024 to reach USD XX million by 2029, at a CAGR of XX% during the forecast period. The wellness industry is prospering with individuals seeking foods that provide enhanced health benefits beyond basic nutrition. This shift in consumer behavior is propelling the demand for seed ingredients in the market. The rising incidence of chronic diseases leads consumers to incorporate seed ingredients into their diets. According to the U.S
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Biotech Ingredients Market - Global Forecast to 2023
Biotech ingredients are large and complex drugs that are structurally identical to compounds found in natural organisms. These medical drugs are produced using complex biotechnological processes, such as genetic engineering and hybridoma technology as well as biopharmaceutical techniques such as recombinant DNA technology, gene transfer, and antibody production methods. Manufacturing of biotech APIs involves the use of microorganisms or genetically modified organisms, or substances produced by living organisms (like enzymes). Biopharmaceuticals include complex proteins such as antibodies, nucleic acids (like DNA and RNA), or antisense oligonucleotides that are produced by methods which are different from direct extraction from natural, non-engineered organisms.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Fiber Food Ingredients Market, By Type Soluble Fiber, Insoluble Fiber, Resistant Fibres, Others) By Function (Cancer
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Mood Ingredients Market - Global Forecast to 2030
The global market for mood ingredients has been estimated to be USD XX billion in 2025 and is projected to grow at XX% between 2025 and 2030. The key players in this market include DSM-Firmenich, Givaudan, Kerry, PLT Health Solutions, Nura USA, NutriScience Innovations, Ixoreal Biomed, Laila Nutraceuticals, OmniActive Health, DolCas Biotech, Suan Farma, NEXIRA, Vidya Herbs, Arjuna Natural, Martin Bauer Group, Kancor Ingredients, Olene Life Sciences, Bioprex Labs, Nattura Bio, Sami-Sabinsa, Indena, Alchem International, Sabinsa Japan, Vidya Europe, and Avestia Pharma.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Agriculture Analytics Market by Offering (Solution and Services), Agriculture Type (Precision Farming, Livestock Farming, Vertical Farming), Technology (Remote Sensing, GIS, Robotics, Automation), Farm Size, End Users and Region - Global Forecast to 2028
The global Agriculture analytics market size is projected to reach USD 2.5 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.1% during the forecast period. The major vendors offering agriculture analytics solutions are Deere & Company(US), IBM(US), Bayer Ag (Germany), SAP(Germany), Trimble(US), Accenture(Ireland), ABACO(Italy), DeLaval(Sweden), Oracle(US), DTN(US), Farmers Edge(Canada), SAS Institute(US), Iteris(US), PrecisionHawk(US), Conservis(US), Stesalit Systems(India), Agribotix(US), Agrivi(UK), Granular(US), FBN(US), Gro Intelligence(US), Resson(Canada), AgVue Technologies(US), Taranis(US), CropX(Israel), Trace Genomics(US), Fasal(India), AgEye Technologies(US), HelioPas AI(Germany), OneSoil (Switzerland), Root AI (US)and AgShift(US).
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Precision Medicine Software Market by Delivery Mode (On-Premise & Cloud-Based), End User (Healthcare Providers, Research Centers & Government Institutes, Pharmaceutical & Biotechnology Companies), Application, and Region - Global Forecast to 2024
The precision medicine software market is projected to reach USD 2.0 billion by 2024, at a CAGR of 11.5%. Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market. However, the high cost of deployment, issues related to the secure storage of large volumes of sequenced data, lack of reimbursement for precision medicine-based treatments, and the dearth of skilled IT professionals in healthcare are expected to restrain market growth to a certain extent in the coming years. Syapse, Inc. (US), 2bPrecise LLC (Israel), Foundation Medicine, Inc. (US), Fabric Genomics (US), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (US), N-of-One, Inc. (US), Human Longevity, Inc. (US), Translational Software, Inc. (US), Sunquest Information Systems Inc. (US), Gene42, Inc. (Canada), LifeOmic Health, LLC (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US), IBM Watson Group (US), and Koninklijke Philips N.V. (Netherlands)
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
US Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The US artificial intelligence (AI) in healthcare market, valued at US$5.98 billion in 2024, stood at US$8.65 billion in 2025 and is projected to advance at a resilient CAGR of 38.0% from 2025 to 2030, culminating in a forecasted valuation of US$43.30 billion by the end of the period. Market growth is driven by rising demand from providers for automation, nationwide labor shortages, increasing clinical complexity, and strong investment in predictive analytics, imaging AI, and GenAI.
- Published: September 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
